NSE · Basic Materials · Agricultural Inputs
EPS came in at -16.79 against a street estimate of -15.90 — a miss of 5.6%.
with an average price target of ₹670.00.
| Holder | Stake |
|---|---|
| Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund | 2.36% |
| Kifs Trade Capital | 1.02% |
| Document | Date |
|---|---|
| Annual report FY2026 ASTEC LIFESCIENCES LIMITED – ANNUAL REPORT FY 2025-26 SUMMARY --- HEADLINE NUMBERS • Consolidated Total Income FY 2025-26: ₹453 crore (vs ₹387 cror | 2026-07-08 |
| Quarterly results · Q4 FY26 ASTEC LIFESCIENCES LIMITED – BOARD MEETING SUMMARY 27 April 2026 --- HEADLINE NUMBERS • Financial year ended 31 March 2026 audited results approved | 2026-04-27 |
| Quarterly results · Q3 FY26 ASTEC LIFESCIENCES LIMITED – FINANCIAL SUMMARY Board Meeting: 30 January 2026 --- HEADLINE NUMBERS • Q3 FY2025-26 Standalone Revenue: Rs 12,472.03 | 2026-01-30 |
| Quarterly results · Q2 FY26 ASTEC LIFESCIENCES LIMITED – FINANCIAL SUMMARY H1 FY2025-26 (Period Ended 30 September 2025) --- HEADLINE NUMBERS • Revenue from Operations (H1): R | 2025-10-29 |
| Quarterly results · Q1 FY26 ASTEC LIFESCIENCES LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q1 FY2025-26 Revenue (Standalone): Rs 9,108.21 Lakh vs Rs 6,937.25 Lakh in Q1 FY20 | 2025-07-28 |
| Annual report FY2025 | 2025-07-04 |
| Quarterly results | 2025-03-12 |
| Quarterly results | 2025-01-27 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Astec LifeSciences Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.